Key result
Recurrent pregnancy loss linked to ~5-fold higher prevalence of thrombophilia vs controls.
Why the study?
Is unexplained recurrent pregnancy loss associated with a higher prevalence of inherited and/or acquired thrombophilia compared to healthy parous controls in women from Southern Italy?
Case-Control (n=190)
No
Is unexplained recurrent pregnancy loss associated with a higher prevalence of inherited and/or acquired thrombophilia compared to healthy parous controls in women from Southern Italy?
After strictly excluding other causes of miscarriage, 78% of women with unexplained recurrent pregnancy loss exhibited inherited or acquired thrombophilia, supporting routine thrombophilia screening and potential antithrombotic prophylaxis in this population.
Answers are grounded in this paper and cite their sources.
Thrombophilia was associated with unexplained recurrent pregnancy loss; leaves open whether screening or prophylaxis improves outcomes.
BACKGROUND: Recurrent fetal loss (RPL) is one of the most common cause of sterility. Several studies identified thrombophilia as the principal cause of recurrent pregnancy loss. However, reported studies often do not evaluate other causes of miscarriages in their inclusion and exclusion criteria. So the aim of our study was to investigate the role of inherited thrombophilia in patients with RPL and without other causes of RPL. PATIENTS AND METHODS: Patients with 2 or more first trimester abortion or with 1 or more late pregnancy loss were considered for this study. In order to evaluate the causes of RPL we looked for chromosomal, endocrine, chronic inflammatory, and infectious alterations. 90 patients affected by unexplained RPL were enrolled and tested for hemostatic alterations. These women were tested for inherited and/or acquired thrombophilia by MTHFR C677T gene polymorphism, factor V Leiden gene polymorphism, PTHRA20210G gene polymorphism, protein S deficiency, protein C deficiency, antithrombin III deficiency, lupus anticoagulant, and anticardiolipin antibodies Ig G and Ig M. RESULTS: Acquired and/or inherited thrombophilia are strongly associated with RPL when other common causes of miscarriage were excluded. 78% of tested women showed hemostatic abnormalities. Several women with combined thrombophilic defects were also identified by our data. CONCLUSION: After a thorough evaluation of other causes of miscarriage women affected by RPL should be tested for thrombophilia. Our data demonstrated 78% of women with one or combined thrombophilic conditions. Differences with previous studies should be related to difference in the inclusion and exclusion criteria and ethnic background. Because these patients often also show a hypercoagulable state, it an antithrombotic treatment before and during pregnancy may improve their clinical outcome (ie, secondary prevention of miscarriage and primary thromboprophylaxis).
No takes yet. Share an insight, caveat, or question.
Pierpaolo Di Micco (2008) conducted a case-control in Unexplained recurrent pregnancy loss (RPL) (n=190). Unexplained recurrent pregnancy loss vs. Healthy age-matched women with >=1 successful pregnancy and no gestational complications or abortions was evaluated on Presence of inherited and/or acquired thrombophilia (p=<0.001). Inherited or acquired thrombophilia was present in 78% of women with unexplained recurrent pregnancy loss compared to 16% of healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: